多种抗生素暴露时长与耐万古霉素肠球菌菌血症风险增加相关:一项巢式病例对照研究
在剑桥大学医院NHS信托基金会2006年1月1日至2012年12月31日住院患者中开展回顾性匹配巢式病例对照研究,235例VRE菌血症病例与220例对照按住院时长、年份、专科和病房类型1:1匹配。暴露于万古霉素、氟喹诺酮类或美罗培南的时长与VRE菌血症独立相关,万古霉素暴露1-3天、4-7天和>7天的条件OR分别为1.2、3.8和6.6。作者认为需针对高风险抗生素开展抗菌药物管理干预以补充感染防控措施。
要点
- 万古霉素、氟喹诺酮类或美罗培南暴露时长与VRE菌血症风险独立相关。
- 与无万古霉素暴露相比,暴露1-3天、4-7天和>7天的风险呈阶梯式升高。
- 中心静脉导管、中性粒细胞减少、低白蛋白血症、恶性肿瘤、胃肠疾病和肝胆疾病也是风险因素。
核心结论
- 较长时间暴露于万古霉素、氟喹诺酮类或美罗培南与VRE菌血症相关。
- 需要针对高风险抗生素的抗菌药物管理干预,以补充针对VRE菌血症的感染防控措施。
研究设计与样本
- 回顾性匹配巢式病例对照研究,纳入剑桥大学医院NHS信托基金会2006年1月1日至2012年12月31日住院患者。
- 235例发生首次VRE菌血症的病例与220例对照按住院时长、年份、专科和病房类型1:1匹配。
- 采用条件logistic回归评估VRE菌血症的独立风险因素。
主要发现
- 与无万古霉素暴露的患者相比,接受1-3天、4-7天或>7天万古霉素疗程者VRE菌血症风险呈阶梯式升高,条件OR分别为1.2(95%CI 0.4-3.8)、3.8(95%CI 1.2-11.7)和6.6(95%CI 1.9-22.8)。
- 中心静脉导管(CVC)存在的条件OR为8.7(95%CI 2.6-29.5)。
- 中性粒细胞减少的条件OR为15.5(95%CI 4.2-57.0)。
- 低白蛋白血症的条件OR为8.5(95%CI 2.4-29.5)。
- 恶性肿瘤的条件OR为4.4(95%CI 1.6-12.0);胃肠疾病的条件OR为12.4(95%CI 4.2-36.8);肝胆疾病的条件OR为7.9(95%CI 2.1-29.9)。
临床怎么用
- 作者认为需要针对高风险抗生素的抗菌药物管理干预,以补充针对VRE菌血症的感染防控措施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: VRE bacteraemia has a high mortality and continues to defy control. Antibiotic risk factors for VRE bacteraemia have not been adequately defined. We aimed to determine the risk factors for VRE bacteraemia focusing on duration of antibiotic exposure. METHODS: A retrospective matched nested case-control study was conducted amongst hospitalized patients at Cambridge University Hospitals NHS Foundation Trust (CUH) from 1 January 2006 to 31 December 2012. Cases who developed a first episode of VRE bacteraemia were matched 1:1 to controls by length of stay, year, specialty and ward type. Independent risk factors for VRE bacteraemia were evaluated using conditional logistic regression. RESULTS: Two hundred and thirty-five cases were compared with 220 controls. Duration of exposure to parenteral vancomycin, fluoroquinolones and meropenem was independently associated with VRE bacteraemia. Compared with patients with no exposure to vancomycin, those who received courses of 1-3 days, 4-7 days or >7 days had a stepwise increase in risk of VRE bacteraemia [conditional OR (cOR) 1.2 (95% CI 0.4-3.8), 3.8 (95% CI 1.2-11.7) and 6.6 (95% CI 1.9-22.8), respectively]. Other risk factors were: presence of a central venous catheter (CVC) [cOR 8.7 (95% CI 2.6-29.5)]; neutropenia [cOR 15.5 (95% CI 4.2-57.0)]; hypoalbuminaemia [cOR 8.5 (95% CI 2.4-29.5)]; malignancy [cOR 4.4 (95% CI 1.6-12.0)]; gastrointestinal disease [cOR 12.4 (95% CI 4.2-36.8)]; and hepatobiliary disease [cOR 7.9 (95% CI 2.1-29.9)]. CONCLUSIONS: Longer exposure to vancomycin, fluoroquinolones or meropenem was associated with VRE bacteraemia. Antimicrobial stewardship interventions targeting high-risk antibiotics are required to complement infection control procedures against VRE bacteraemia.
引用
- Gouliouris T, Warne B, Cartwright EJP, et al. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study. J Antimicrob Chemother. 2018. PMID: 29548009. doi:10.1093/jac/dky075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。